VEGF-Induced Neoangiogenesis Is Mediated by NAADP And
VEGF-induced neoangiogenesis is mediated by NAADP + and two-pore channel-2–dependent Ca2 signaling Annarita Faviaa, Marianna Desiderib, Guido Gambaraa, Alessio D’Alessioa,c, Margarida Ruasd, Bianca Espositoa, Donatella Del Bufalob, John Parringtond, Elio Ziparoa, Fioretta Palombia, Antony Galioned,1,2, and Antonio Filippinia,1,2 aDepartment of Anatomy, Histology, Forensic Medicine and Orthopaedics, Unit of Histology and Medical Embryology, Sapienza University of Rome, 00161 Rome, Italy; bExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, 00128 Rome, Italy; cInstitute of Histology and Embryology, Catholic University of the Sacred Heart, 00168 Rome, Italy; and dDepartment of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom Edited* by Michael J. Berridge, The Babraham Institute, Cambridge, United Kingdom, and approved September 24, 2014 (received for review April 3, 2014) Vascular endothelial growth factor (VEGF) and its receptors VEGFR1/ strategies nullify the success of such interventions (5, 7, 8). Re- VEGFR2 play major roles in controlling angiogenesis, including sistance to anti-VEGF therapies may occur through a variety of + vascularization of solid tumors. Here we describe a specific Ca2 mechanisms, including evocation of alternative compensatory signaling pathway linked to the VEGFR2 receptor subtype, control- factors, selection of hypoxia-resistant tumor cells, action of ling the critical angiogenic responses of endothelial cells (ECs) to proangiogenic circulating cells, and increased
[Show full text]